Maekawa Masato
Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.
Rinsho Byori. 2010 Jan;58(1):58-63.
Measurement of the catalytic activity concentration of enzymes has been standardized using a traceability chain, consisting a reference measurement system for enzyme catalytic activity and reference standard-JSCC enzyme. The Japan Medical Association (JMA) has provided an external quality assessment (EQA) survey program for clinical laboratory testing. More than 3,100 clinical laboratories participated in 2008. The EQA program indicated that standardization of the measurement of the catalytic activity concentration of enzymes has been completed for AST, ALT, LD, ALP, gammaGT, and CK in more than 90% laboratories, and for Amy and ChE in nearly 80% of laboratories. Because such a large survey program must use artificial specimens, a matrix effect cannot be avoided, especially in dry chemistry. However, the bias produced by a matrix effect usually has a predictable tendency: it can be corrected. Next, after standardization of the measurement of the catalytic activity concentration of enzymes, we should develop and use common reference intervals. On completing the standardization, we can make standard medical decisions using reference measurement systems and rules.
酶催化活性浓度的测量已通过一条可溯源链实现标准化,该可溯源链由酶催化活性的参考测量系统和参考标准品——日本临床化学学会(JSCC)酶组成。日本医学协会(JMA)为临床实验室检测提供了一项外部质量评估(EQA)调查计划。2008年有超过3100家临床实验室参与其中。EQA计划表明,超过90%的实验室已完成了天冬氨酸氨基转移酶(AST)、丙氨酸氨基转移酶(ALT)、乳酸脱氢酶(LD)、碱性磷酸酶(ALP)、γ-谷氨酰转移酶(gammaGT)和肌酸激酶(CK)酶催化活性浓度测量的标准化,近80%的实验室完成了淀粉酶(Amy)和胆碱酯酶(ChE)的标准化。由于如此大规模的调查计划必须使用人工标本,基质效应无法避免,尤其是在干化学中。然而,基质效应产生的偏差通常具有可预测的趋势:它是可以校正的。接下来,在酶催化活性浓度测量标准化之后,我们应该制定并使用通用的参考区间。完成标准化后,我们可以使用参考测量系统和规则做出标准的医学决策。